Build an Inve Case for PRE → Read the full call →
Prenetics (PRE) earnings
Prenetics earnings: last reported Tue, 18 Aug 2026, for the quarter ended Jun 2026.
Prenetics earnings callsPrenetics earnings calls (PRE)
Latest concall · Q2 2026 · call held call held 18 Aug 2026
Prenetics Q2 FY26 — Record Revenue, Positive Adjusted FCF, and Raised FY26/FY27 Guidance
What went well
- Consolidated adjusted free cash flow turned positive for the first time in July 2026, with Q3 FY26 expected to be the first positive quarter.
- Q2 FY26 total revenue reached $46.5 million, up 29% sequentially and 3.9x year-over-year, marking the sixth consecutive record quarter.
- July 2026 revenue hit a record $20.9 million, an annualized run rate of $251 million, and 4.3x of July 2025.
What to watch
- Adjusted EBITDA for Q2 FY26 was negative $19 million, primarily due to increased marketing spend.
- Net loss for Q2 FY26 was $9 million, or $0.52 per share.
Performance +70.2% 1Y
1Y: $13.59 on 29 Sept 2025 → $23.13. High $26.25 (27 Aug 2026), low $11.79 (17 Nov 2025).
Balance sheet
| Year ending | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|
| Total liabilities | — | $549.40M | $68.67M | $44.01M | $42.23M |
| Fixed assets | — | $13.04M | $13.10M | — | — |
| Total assets | — | $148.51M | $312.13M | $254.17M | $213.57M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
14 filings between Jun 15, 2026 and Sep 4, 2026.
Open market
decisions to buy or sellPurchases
$999.7K
5 purchases by 2 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 8
- Option exercise — converted options into shares
Also filed: 1 other.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Yeung Danny Sheng Wu | $502.0K | — | Aug 24, 2026 |
| Rosin Brian J | $497.7K | — | Aug 25, 2026 |
Latest filings (14)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Leogrande Hudson Blake Director | Option exercise | 2,000 | $0 |
| Aug 25, 2026 | Rosin Brian J CFO of IM8 (US) LLC | Purchase | 5,100 | $116.3K |
| Aug 24, 2026 | Rosin Brian J CFO of IM8 (US) LLC | Purchase | 18,000 | $381.4K |
| Aug 24, 2026 | Yeung Danny Sheng Wu Chief Executive Officer | Purchase | 6,000 | $125.4K |
| Aug 24, 2026 | Yeung Danny Sheng Wu Chief Executive Officer | Purchase | 11,181 | $239.3K |
| Aug 21, 2026 | Lo Hoi Chun Chief Financial Officer | Option exercise | 32,736 | $3 |
| Aug 21, 2026 | Lo Hoi Chun Chief Financial Officer | Option exercise | 45,815 | $0 |
| Aug 20, 2026 | Yeung Danny Sheng Wu Chief Executive Officer | Option exercise | 53,953 | $5 |
| Aug 20, 2026 | Yeung Danny Sheng Wu Chief Executive Officer | Purchase | 7,500 | $137.3K |
| Aug 20, 2026 | Yeung Danny Sheng Wu Chief Executive Officer | Other | 49,912 | $0 |
| Aug 4, 2026 | Leogrande Hudson Blake Director | Option exercise | 2,001 | $0 |
| Jul 4, 2026 | Leogrande Hudson Blake Director | Option exercise | 2,000 | $0 |
| Jun 15, 2026 | VANDERVEEN DAVID Director | Option exercise | 6,944 | $0 |
| Jun 15, 2026 | Cheng Yin Pan Director | Option exercise | 15,873 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.